Looking forward to a fruitful international discussion today on this innovative topic! #R2R2022 #innovation #collaboration #mentalhealth

Final day of then conference begins! Dr. Katherine Bonson gives us an overview of day 3 #R2R2022

Dr. Devon Christie - Best in class presentation on ketamine assisted therapy (KAT) at the Research to Reality Global summit on psychedelic-assisted therapies and medicine #R2R2022 Clear articulation of impressive expertise.

Dr. Devon Christie lays out the financial barriers to #ketamine therapies. Limited billing codes limited coverage of psychotherapy means high costs for people seeking theses services and that means big equity issues. #R2R2022

.Darron Smith provides some background on the history of #psychedelics and politics as part of his presentation on the need for psychedelic-assisted therapy in the Black community #R2R2022

.Darron Smith says that strides are being made towards more research around psychedelic-assisted therapies with and for Black communities From Research to Reality #R2R2022

Grateful for the opportunity to present a poster on study protocols for psychedelic-assisted therapy in #OCD and #BDD at From Research to Reality

Very grateful to have the chance to share our team's work on #suicidality at #R2R2022 (and to see all of the other incredible #psychedelic #research being done)! Full paper available at pubs.acs.org/doi/10.1021/ac… 💡 From Research to Reality Rick Zeifman Cory Weissman UofTPsychiatry

Wow! The future looks bright for psychedelic assisted therapy and psychedelic access in general. Looking forward to seeing how all this unfolds. Thanks Rick Doblin, Ph.D., of MAPS for the insightful From Research to Reality presentation!

Loved #R2R2022 From Research to Reality Conference on #psychedelics combining top tier scientific research w/concerted effort to amplify indigenous voices. H/t Source Research Foundation for supporting my work on attachment theory's potential contribution to psychedelic-assisted therapy

Thanks Dr. Doris Payer for convening international regulation panel. Dr. Javier Muniz from FDA lays out the unique challenges for clinical trial regulators given the complex mix of pharmacological and psychotherapeutic interventions. #R2R2022

Dr. Jorge Julio Gonzalez Olvera: under Mexican Mental Health Strategy, no one is outside. Everyone must be inside the strategy from a population health perspective. #mentalhealth  starts with the community. #R2R2022

Amazing closing plenary on #psychedelics in #mentalhealth & #addictions treatment at #R2R2022 - always love hearing the inimitable Matthew W. Johnson of Johns Hopkins Psychedelic Research Center speak! Leaving this conference feeling very hopeful about the future of this field 🤞 From Research to Reality

Thanks to everyone who advised, contributed, participated and attended #R2R2022. It’s been a wonderful few days sharing knowledge and forging new relationships. Let’s continue the conversations!

Elder Clayton Shirt closes #R2R2022 with a prayer: “There are many views here, but we can all agree that we are people, human beings… These medicines can help up reconnect to what it is to be a human being.”

That’s a wrap! What an awesome conference. Such a great experience to learn from colleagues and come together with the shared vision of moving psychedelic-assisted therapy from research to reality!! From Research to Reality #r2r2022 #Toronto #psychedelics #mentalhealth

“You can’t do good therapy with Black and Brown people in America if you don’t have some rudimentary understanding and appreciation of the traumatic history that we’ve experienced." Monnica Williams Psychedelics Today Chacruna Institute MAPS From Research to Reality psychedelicstoday.com/2022/07/26/pt3…